FDA-Ya yarda da maganin ƙwayar cuta ta Cutar

Magunguna da bayar da magani da yawa na as high as 99 bisa dari

Lokacin da aka fara gabatar da miyagun ƙwayoyi Sovaldi (Sofosbuvir) a cikin watan Satumba na shekarar 2014, ba kawai ya nuna canjin yanayi ba game da yadda cutar ta kamu da ciwon hauka na ciwon hawan Cutar da ciwon hawan Cutar da ke cikin cutar , wanda ya kasance ba shi da wani tasiri. A cikin watanni na zuwan Sovaldi, irin waɗannan maganganun hepatitis C kamar yadda aka hada (telaprevir) da Victrelis (boceprevir) an cire su daga kasuwa, ba za a sake ganin su ba.

Biran da sauri a kan sheqa na Sovaldi shi ne gabatarwar wasu samfurorin ƙarin magani guda shida da za su iya magance yanayin ci gaba da jigilar cutar Hizitis C. Wadannan magungunan sababbin kwayoyi ba wai kawai sun samar da mummunan sakamako ba, sun rage tsarin farfadowa har tsawon watanni uku.

Da maganin magani yanzu ya wuce kashi 95 a cikin lokuta da yawa, ƙalubalen gaske shi ne yadda za a fadada yawan mutane 130 zuwa 150 wadanda ke fama da ciwon hauka C a dukan duniya.

A nan ne wasu sababbin sabbin abubuwa guda takwas na ilimin cutar hepatitis C, wanda aka tsara ta hanyar umarnin FDA:

1 -

Rafta
Hotuna kyauta ta Hotuna

An amince da shi ranar 28 ga Yuni, 2016, Epclusa (sofosbuvir, velpatasvir) wani kwamfutar da ke haɗuwa guda biyu wanda zai iya magance dukkanin ciwon kwayoyin cutar ciwon hawan C shida. Ana iya amfani dashi don bi da mutanen da ke da cirrhosis (ciki har da cirrhosis da yawa ). An tsara takarda a cikin kowace rana na tsawon mako daya zuwa shida.

Kara

2 -

Zepatier
Merck mai girmamawa

An amince da shi a watan Janairu 2016, Zepatier (elbasvir, grazoprevir) wani maganin hade ne mai maganin maganin da ake amfani dasu don bi da jinsin 1 da 4 tare da ko ba tare da cirrhosis ba. Zepatier kwayar cutar guda daya ce wadda ba ta buƙata a gudanar da shi tare da wani magani. Ana dauka sau ɗaya kowace rana tare da ba tare da abinci ba don makonni 12 zuwa 16, dangane da irin kwayar da mutum ke da kuma ko an riga an yi wa mutumin azabtarwa don cutar hepatitis C.

Kara

3 -

Daklinza
Mai ladabi: Bristol Myer Squibb

An amince da shi a watan Yuli na shekarar 2015, Daklinza (daclatasvir) ana amfani dasu wajen maganin cutar ciwon hawan Citotyp C genotype 3. Daklinza ita ce ta farko da za ta iya magance kwayar cutar ta 3 kawai ba tare da tarawa na peginterferon ko ribavirin ba . Ana daukar Daklinza tare da Sovaldi sau ɗaya a kullum tare da ko ba tare da abinci ba don tsawon makonni 12.

Kara

4 -

Technivie
AbbVie mai ladabi

An amince da shi a watan Yuli na shekarar 2015, Technivie (ombitasvir, paritaprevir / ritonavir) wani magani ne wanda ake amfani dashi don magance mutanen da ke dauke da kwayar cutar ta genotype 4. Ma'aikatan miyagun ƙwayoyi guda uku da suka hada da Technivie sun haɗa su a cikin nau'in kwayoyi guda biyu, Viekira Pak . Samfurin da aka bayar da shawarar shine allunan biyu da aka ɗauki sau biyu a kowace rana tare da ribavirin tsawon makonni 12.

Kara

5 -

Viekira Pak

An amince da shi a cikin watan Disamba na shekarar 2014, Viekira Pak wani maganin maganin likitanci ne wanda aka yi amfani da shi don magance ilimin cutar ciwon haifa C na kwayar cutar 1 tare da ko ba tare da cirrhosis ba. Shirin ya hada da miyagun ƙwayoyi Technivie co-kunshe tare da wani ƙarin magani da ake kira dasabuvir. Samfurin da aka ba da shawara shi ne allunan biyu na Technvie da aka dauka sau ɗaya kowace rana tare da abinci da ɗayan littafi na dasabuvir dauka sau biyu tare da abinci. Zamanin magani yana daga makon 12 zuwa 24.

Kara

6 -

Harvoni

An amince da shi a watan Oktobar 2014, Harvoni (jagoran jagorancin, sofosbuvir) wani maganin hadewa ne mai maganin maganin cutar da ake amfani dasu don cutar da cutar 1 da 4 tare da ko ba tare da cirrhosis ba. Ana iya amfani da shi a wasu lokuta na kwayar cutar 3. Harvoni ita ce farko, tsarin jinsin da ke ciki wanda ba ya buƙatar gwamnati tare da peginterferon ko ribavirin. Samun da aka bayar da shawarar shine ɗaya daga kwamfutar hannu kowace rana ana ɗauke tare da ko ba tare da abinci ba. Zamanin magani yana daga makon 12 zuwa 24.

Kara

7 -

Sovaldi
Aikin kula da ilimin kimiyya na Gileyad

An amince da shi a watan Disambar 2013, Sovaldi (sofosbuvir) wani littafi ne mai amfani da maganin rigakafi wanda ke amfani dasu don magance jinsin 1, 2, 3 da 4. Sakamakon shawarar ita ce ɗayan lissafi kowace rana tare da ko ba tare da abinci ba. Dangane da genotype, za a iya ribavirin a cikin farfadowa. Domin kamuwa da kamuwa da kwayar cutar 3, Sovaldi yana tare da Daklinza. Zamanin magani yana daga makon 12 zuwa 24.

Kara

8 -

Olysio
Hotuna mai kula da Janssen Pharmaceuticals

An amince da shi a watan Nuwambar 2013, Olysio (simeprevir) wani maganin rigakafi ne na protease da ake amfani dashi don magance mutanen da ke fama da ciwon cutar Citotype C. Ana amfani da Olysio a hade tare da duka launi da ribavirin don tsawon makonni 24 zuwa 36. Samun da aka bayar da shawarar ita ce kwamfutar hannu ɗaya da abinci.

Kara